February 21, 2022
BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 21, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. ( PGDx ), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.